Trading Members of the Exchange are hereby informed that effective from September 01, 2026, the Equity Shares of Symbiotec Pharmalab Ltd (Scrip Code: 544889) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20260831- dated August 31, 2026.